Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An acute myeloid leukemia secondary to a myelodysplastic syndrome or therapy-related. (WHO, 2001)
Biomarker and diagnostic research for therapy related acute myeloid leukemia and myelodysplastic syndrome has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include drug therapy and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
152 publications have been identified in PubMed for therapy related acute myeloid leukemia and myelodysplastic syndrome. Research spans Clinical Trial Publication (31%), Basic Science / Preclinical (23%), and Review / Meta-Analysis (22%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 47 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 10:23 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
31%
Laboratory research | 35 | 23% |
Research summaries | 33 | 22% |
Disease patterns and progression | 17 | 11% |
Testing and diagnosis research | 6 | 4% |
Patient case studies | 6 | 4% |
New treatment approaches | 5 | 3% |
Other research | 3 | 2% |
Montesinos P (2026). [PMID: 41082703](https://pubmed.ncbi.nlm.nih.gov/41082703/). *Journal of clinical oncology : official journal of the American Society of Clinical Oncology*. [Clinical Trial Publication]
Ishihara RT (2026). [PMID: 40369741](https://pubmed.ncbi.nlm.nih.gov/40369741/). *Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society*. [Case Report / Case Series]
Stemler J (2026). [PMID: 41655623](https://pubmed.ncbi.nlm.nih.gov/41655623/). *International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases*. [Review / Meta-Analysis]
Kantarjian H (2026). [PMID: 41761287](https://pubmed.ncbi.nlm.nih.gov/41761287/). *American journal of hematology*. [Gene Therapy / Novel Therapeutics]
Mei H (2026). [PMID: 41332324](https://pubmed.ncbi.nlm.nih.gov/41332324/). *Adv Sci (Weinh)*. [Gene Therapy / Novel Therapeutics]
Chien KS (2026). [PMID: 41469316](https://pubmed.ncbi.nlm.nih.gov/41469316/). *Clin Lymphoma Myeloma Leuk*. [Clinical Trial Publication]
Matsukawa T (2026). [PMID: 41666291](https://pubmed.ncbi.nlm.nih.gov/41666291/). *Hematology*. [Basic Science / Preclinical]
Baccelli F (2026). [PMID: 42163725](https://pubmed.ncbi.nlm.nih.gov/42163725/). *Haematologica*. [Clinical Trial Publication]
Sharma M (2026). [PMID: 41614533](https://pubmed.ncbi.nlm.nih.gov/41614533/). *European stroke journal*. [Clinical Trial Publication]
Arcourt A (2026). [PMID: 41098113](https://pubmed.ncbi.nlm.nih.gov/41098113/). *Haematologica*. [Epidemiology / Natural History]